The 17α-Hydroxyprogesterone Assay Kit (Time-Resolved Fluorescence Method) is a specialized diagnostic tool used to measure the concentration of 17α-hydroxyprogesterone in neonatal dried blood spots. This kit is essential for early detection of congenital adrenal hyperplasia (CAH), a condition that can lead to severe health complications if not diagnosed and treated promptly. The kit employs advanced time-resolved fluorescence technology, ensuring high sensitivity and accuracy in measurements.

1. The kit features a highly sensitive time-resolved fluorescence method, which allows for precise detection of 17α-hydroxyprogesterone levels even at low concentrations. This method is particularly useful in neonatal screening, where early detection is critical.
2. The kit includes a comprehensive set of components, such as calibrators, controls, and specialized buffers, all designed to ensure accurate and reproducible results. The use of europium-labeled reagents enhances the fluorescence signal, improving the overall sensitivity of the assay.
3. The primary application of this kit is in the screening of newborns for congenital adrenal hyperplasia (CAH). By measuring 17α-hydroxyprogesterone levels, healthcare providers can identify infants at risk for CAH and initiate early treatment, thereby preventing potential complications.

The 17α-Hydroxyprogesterone Assay Kit is a vital tool in neonatal screening, offering high sensitivity and accuracy in detecting 17α-hydroxyprogesterone levels. Its advanced time-resolved fluorescence method and comprehensive components make it an indispensable resource for early diagnosis of congenital adrenal hyperplasia.

The main features of this kit include high sensitivity, accuracy, and ease of use, making it ideal for neonatal screening.

1. High Sensitivity: The time-resolved fluorescence method ensures that even low concentrations of 17α-hydroxyprogesterone can be detected with precision.
2. Comprehensive Components: The kit includes all necessary reagents and controls, ensuring accurate and reproducible results.
3. Ease of Use: The kit is designed for straightforward operation, with clear instructions and user-friendly components.
4. Early Detection: The kit is specifically designed for neonatal screening, allowing for early detection of congenital adrenal hyperplasia.
5. Quality Assurance: Each kit comes with a quality control certificate, ensuring that the batch meets stringent quality standards.

The 17α-Hydroxyprogesterone Assay Kit stands out for its high sensitivity, comprehensive components, and ease of use. These features make it an essential tool for neonatal screening, particularly in the early detection of congenital adrenal hyperplasia.

This kit is primarily used in clinical settings for the early detection of congenital adrenal hyperplasia in newborns.

1. Neonatal Screening: The kit is widely used in neonatal screening programs to detect congenital adrenal hyperplasia (CAH) early in life.
2. Diagnostic Confirmation: It is also used to confirm diagnoses in cases where initial screening results indicate elevated 17α-hydroxyprogesterone levels.
3. Monitoring Treatment: The kit can be used to monitor the effectiveness of treatment in infants diagnosed with CAH.
4. Research Applications: Researchers use this kit to study the prevalence and impact of CAH in different populations.
5. Public Health Programs: The kit is a key component in public health initiatives aimed at reducing the incidence of CAH-related complications.

The 17α-Hydroxyprogesterone Assay Kit is a crucial tool in clinical settings, particularly for neonatal screening and the early detection of congenital adrenal hyperplasia. Its applications extend to diagnostic confirmation, treatment monitoring, and research, making it a versatile and valuable resource in healthcare.

This guide provides essential information for purchasing the 17α-Hydroxyprogesterone Assay Kit, including product specifications, types, budget considerations, and usage scenarios.

1. Product Specifications: The kit includes specific components such as calibrators, controls, and buffers, all designed for accurate 17α-hydroxyprogesterone measurement.
2. Product Types: The kit is available in different configurations to meet various laboratory needs, including bulk purchasing options.
3. Budget Considerations: When purchasing, consider the volume of tests required and the long-term cost-effectiveness of the kit.
4. Usage Scenarios: The kit is ideal for neonatal screening programs, diagnostic labs, and research institutions focused on congenital adrenal hyperplasia.

Purchasing the 17α-Hydroxyprogesterone Assay Kit requires careful consideration of product specifications, types, and budget. Understanding the usage scenarios will help ensure that the kit meets the specific needs of your laboratory or healthcare facility.

Proper handling and storage of the 17α-Hydroxyprogesterone Assay Kit are essential to ensure accurate results and maintain the integrity of the components.

1. Storage Conditions: Store the kit at the recommended temperature to prevent degradation of the reagents.
2. Handling Precautions: Use aseptic techniques when handling the kit components to avoid contamination.
3. Expiration Dates: Always check the expiration dates on the kit components before use.
4. Quality Control: Regularly perform quality control checks to ensure the kit is functioning correctly.
5. Disposal: Dispose of used components according to local regulations for biohazardous materials.

To ensure the accuracy and reliability of the 17α-Hydroxyprogesterone Assay Kit, it is crucial to follow proper storage, handling, and disposal procedures. Regular quality control checks and adherence to expiration dates will help maintain the kit's performance and ensure consistent results.